Clik here to view.
Rebalancing the Immune System
Novel therapy to increase beneficial immune cells shows promise in pilot type 1 diabetes clinical study Type 1 diabetes (T1D) is caused when a person’s immune system mistakenly destroys their...
View ArticleClik here to view.
A New Switch Hitter for Type 1 Diabetes Discovered
Pancreatic cells are more adaptable and possess a greater potential for self-healing than previously assumed For decades, the prevailing wisdom was that beta cells could not regenerate and that their...
View ArticleClik here to view.
Improving Beta Cell Health and Survival
JDRF-funded clinical study to test marketed drug to improve beta cell health and survival in T1D JDRF recently awarded a $2.1 million grant to Anath Shalev, M.D., director of the University of...
View ArticleClik here to view.
Unlocking a Combination Therapy for New Onset T1D
A new study is further assessing if a novel combination of drugs could help treat new onset type 1 diabetes University of Florida researchers are ready to launch a new clinical study to examine if a...
View ArticleClik here to view.
Re-educating the Immune System in T1D
JDRF partner Selecta developed a novel technology for creating a T1D vaccine to potentially halt the disease process It has been more than 30 years since scientists identified the basic autoimmune...
View ArticleInvestigating the Role of Regulatory T Cells in T1D
A video explains a potential new immune therapy in the words of the T1D investigator and one of the clinical study participants JDRF Research in the Field spoke to the lead investigator, Dr. Stephen...
View Article